Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Pancreatic Neoplasms 35Carcinoma, Non-Small-Cell Lung 26Breast Neoplasms 13Lung Neoplasms 12Triple Negative Breast Neoplasms 11Neoplasm Metastasis 10Neoplasms 8Colorectal Neoplasms 8Squamous Cell Carcinoma of Head and Neck 4Carcinoma, Pancreatic Ductal 4Parkinson Disease 4, Autosomal Dominant Lewy Body 3Head and Neck Neoplasms 3Gastrointestinal Neoplasms 3Esophageal Squamous Cell Carcinoma 3Vaccinia 2Stomach Neoplasms 2Rectal Neoplasms 2Ovarian Neoplasms 2Neoplasms by Site 2Gallbladder Neoplasms 2Fallopian Tube Neoplasms 2Endometrial Neoplasms 2Colonic Neoplasms 2Carcinoma 2Brain Neoplasms 2Adenocarcinoma 2Uterine Cervical Neoplasms 1Thyroid Neoplasms 1Squamous Non-small Cell Lung Cancer 1Solid Tumor 1

Interventions

relacorilant 1Bevacizumab 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Fallopian Tube Diseases × 130-nm albumin-bound paclitaxel × 90 days × Clear all
NCT06906341 2026-04-14

Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers

Corcept Therapeutics

Phase 2 Recruiting
270 enrolled
Gynecologic

Fallopian Tube Diseases, Fallopian Tube Neoplasms, Genital Neoplasms, Female, Neoplasms, Neoplasms by Site, Ovarian Diseases, Ovarian Neoplasms, Peritoneal Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡